HolderBook

NOVUS THERAPEUTICS INC (NVUS)

Institutional ownership reported to the SEC as of Q4 2020, across 9 quarters.

17
Reporting holders
$87.8M
Reported value
0.0%
Calls
0.0%
Puts
-1
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
Cormorant Asset Management, LP$21.4M1,415,5000.51%newNEW
FMR LLC$15.5M1,004,1110.00%newNEW
ADAGE CAPITAL PARTNERS GP, L.L.C.$13.7M892,5550.03%newNEW
Woodline Partners LP$13.7M892,5550.36%newNEW
BVF INC/IL$11.8M763,2790.46%newNEW
Logos Global Management LP$3.5M224,0710.30%newNEW
Stonepine Capital Management, LLC$2.6M167,3331.97%newNEW
Maven Securities LTD$1.7M111,5550.17%newNEW
Asymmetry Capital Management, L.P.$1.2M80,0690.56%2q-92.6%-$15.5M
ORBIMED ADVISORS LLC$1.1M73,6500.01%newNEW
MORGAN STANLEY$683.0K44,3780.00%newNEW
RENAISSANCE TECHNOLOGIES LLC$666.0K43,2510.00%newNEW
BlackRock Inc.$165.0K10,6970.00%newNEW
VANGUARD GROUP INC$62.0K4,0430.00%newNEW
Tower Research Capital LLC (TRC)$40.0K2,5980.00%newNEW
Rockefeller Capital Management L.P.$25.0K1,6660.00%newNEW
BANK OF AMERICA CORP /DE/$16.0K1,0200.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q4 202017$87.8M5,732,33116010.0%
Q3 202018$6.1M6,464,6779410.0%
Q2 202015$2.8M6,079,1598310.0%
Q1 20209$2.1M5,387,6922130.0%
Q4 20199$2.8M4,870,7631240.0%
Q3 201913$3.4M5,548,0822250.0%
Q2 201920$5.9M5,874,2127920.0%
Q1 201915$13.6M3,377,7723350.0%
Q4 201814$5.4M3,399,7090010.0%